title: Characterization of a novel TPMT mutation associated with azathioprine-induced myelosuppression.
authors.forename: Tiphaine Adam
authors.initials: TA
authors.lastname: de Beaumais
authors.forename: May
authors.initials: M
authors.lastname: Fakhoury
authors.forename: Benedicte
authors.initials: B
authors.lastname: Pigneur
authors.forename: Sheila
authors.initials: S
authors.lastname: Viola
authors.forename: Yves
authors.initials: Y
authors.lastname: Medard
authors.forename: Franck
authors.initials: F
authors.lastname: Broly
authors.forename: Evelyne
authors.initials: E
authors.lastname: Jacqz-Aigrain
mesh_terms: D000963:Antimetabolites / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use*; D002648:Child; D005260:Female; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism; D008780:Methyltransferases / Q000187:drug effects* / Q000235:genetics; D009154:Mutation; D010375:Pedigree; D011110:Polymorphism, Genetic / Q000235:genetics*; D016896:Treatment Outcome
chemical_list: D000963:Antimetabolites; D008780:Methyltransferases; C022745:thiopurine methyltransferase; D001379:Azathioprine